Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Ivana Veljić

Lipoprotein Apheresis and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors: Do We Have a Vanquishing New Strategy?

European Journal of Preventive Cardiology

Cardiovascular Medicine

English

Related publications

Lipoprotein(a) and Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors

Clinical Research in Cardiology Supplements

Nuclear Medicine

Molecular Biology

Structural Biology

English

Lipoprotein(a) and Inhibitors of Proprotein Convertase Subtilisin/Kexin Type 9

Journal of Thoracic Disease

Respiratory Medicine

English

Cost Effectiveness of Proprotein Convertase Subtilisin/ Kexin Type 9 (PCSK9) Inhibitors

Cardiovascular Disorders and Medicine

English

Proprotein Convertase Subtilisin/Kexin Type-9 (PCSK-9) Inhibitors Induced Liver Injury - A Retrospective Analysis

Journal of Community Hospital Internal Medicine Perspectives

Internal Medicine

English

PCSK6 (Proprotein Convertase Subtilisin/Kexin Type 6)

Atlas of Genetics and Cytogenetics in Oncology and Haematology

Cancer Research

English

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Single Domain Antibodies Are Potent Inhibitors of Low Density Lipoprotein Receptor Degradation

Journal of Biological Chemistry

Molecular Biology

English

Management of Patients Eligible for Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibitors: Economic Impact and Reform Proposals

Global and Regional Health Technology Assessment

English

Comparative Effects of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) and Statins on Postprandial Triglyceride-Rich Lipoprotein Metabolism

Arteriosclerosis, Thrombosis, and Vascular Biology

Cardiovascular Medicine

English

Variations of the Proprotein Convertase Subtilisin/Kexin Type 9 Gene in Coronary Artery Disease

Journal of International Medical Research

English